# Ustekinumab for Active Sight-Threatening Uveitis

> **NCT01647152** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **National Eye Institute (NEI)**

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Ustekinumab

## Key facts

- **NCT ID:** NCT01647152
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-07-03
- **Primary completion:** 2015-06-30
- **Final completion:** 2015-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01647152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01647152, "Ustekinumab for Active Sight-Threatening Uveitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01647152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*